BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 47 found
  Current Search:  contracture: 47     

HTML
100%
Stretching Improves Shoulder Contracture, Arm Pain in Kids Who Play Baseball
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

To find out how to adjust your browser settings to accept cookies, please click here.

Medscape uses cookies to customize the site based on the information...

Abstracts in Hematology and Oncology:  Mar 11 2010 8:23PM
Matching: contracture
Find similar documents
HTML
100%
Stretching Improves Shoulder Contracture, Arm Pain in Kids Who Play Baseball
_ Stretching Improves Shoulder Contracture, Arm Pain in Kids Who Play Baseball.
Medscape:  Mar 11 2010 7:02PM
Matching: contracture
Find similar documents
HTML
100%
Auxilium Announces Availability Of XIAFLEXTM For The Treatment Of Dupuytren's Contracture
Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, announced that XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, is now available by prescription in the United States...

Medical News Today:  Mar 9 2010 8:16AM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of Xiaflex for the Treatment of Dupuytren's Contracture
LYNBROOK, N.Y., March 8 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp.

( NASDAQ:BSTC) , a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX(TM) is now available in the U.S.

by...

Pharma Live:  Mar 9 2010 1:49PM
Matching: contracture
Find similar documents
HTML
100%
Medical News: Auxilium Announces Availability Of XIAFLEXTM For The Treatment Of Dupuytren's Contracture
Auxilium Pharmaceuticals, Inc.

(NASDAQ: AUXL), a specialty biopharmaceutical company, announced that XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, is now available by prescription in the United States...

BioFind:  Mar 9 2010 11:58AM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
LYNBROOK, N.Y., March 8 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription,...

SmartBrief:  Mar 8 2010 10:32PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Memphis Business Journal:  Mar 8 2010 10:22PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Sacramento Business Journal:  Mar 8 2010 10:17PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Portland Business Journal:  Mar 8 2010 10:12PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Charlotte Business Journal:  Mar 8 2010 10:11PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

San Francisco Business Times:  Mar 8 2010 10:11PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Phoenix Business Journal:  Mar 8 2010 10:09PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Orlando Business Journal:  Mar 8 2010 10:02PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Los Angeles Business:  Mar 8 2010 9:43PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Business Journal of Tampa Bay:  Mar 8 2010 9:41PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Wichita Business Journal:  Mar 8 2010 9:35PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Denver Business Journal:  Mar 8 2010 9:24PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Business Journal of Milwaukee:  Mar 8 2010 9:20PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Cincinnati Business Journal:  Mar 8 2010 9:17PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Cincinnati Business Journal:  Mar 8 2010 9:14PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Austin Business Journal:  Mar 8 2010 8:59PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

New Mexico Business Weekly:  Mar 8 2010 8:57PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Business Review Albany:  Mar 8 2010 8:57PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

San Jose Business Journal:  Mar 8 2010 8:55PM
Matching: contracture
Find similar documents
HTML
100%
BioSpecifics Technologies Corp. Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
BioSpecifics Technologies Corp.

(Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX is now available in the U.S.

by prescription, for the treatment of adult Dupuytren's contracture...

Biz Journals:  Mar 8 2010 8:53PM
Matching: contracture
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.